AN2 Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANTX Nasdaq 2836 www.an2therapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AN2 Therapeutics, Inc.

AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock? - Jan 9th, 2026 10:00 am
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? - Jan 9th, 2026 7:40 am